Prosecution Insights
Last updated: October 04, 2026
Application No. 18/428,193

METHOD OF USING/APPLYING A KERATIN HYDROLYSIS PEPTIDE SOLUTION TO ENHANCE PRODUCTION YIELD OF TOMATO FRUITS UNDER HOT WEATHER CONDITION

Non-Final OA §112§DP
Filed
Jan 31, 2024
Priority
Nov 03, 2023 — TW 112142535
Examiner
CONIGLIO, AUDREA JUNE BUCKLEY
Art Unit
1617
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Ch Biotech R&D Co. Ltd.
OA Round
3 (Non-Final)
53%
Grant Probability
Moderate
3-4
OA Rounds
7m
Est. Remaining
74%
With Interview

Examiner Intelligence

Grants 53% of resolved cases
53%
Career Allowance Rate
452 granted / 855 resolved
-7.1% vs TC avg
Strong +21% interview lift
Without
With
+21.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
46 currently pending
Career history
894
Total Applications
across all art units

Statute-Specific Performance

§101
1.1%
-38.9% vs TC avg
§103
51.9%
+11.9% vs TC avg
§102
8.9%
-31.1% vs TC avg
§112
25.6%
-14.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 855 resolved cases

Office Action

§112 §DP
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 8/6/2026 has been entered. Status of the Claims Claims 1-8 remain pending and under current examination. Response to Arguments and Withdrawn Rejections Applicant’s arguments filed 8/6/2026 (hereafter, “Remarks”) have been fully considered and are addressed as follows. The particular rejections of claims 2, 4, 6, and 8 under 35 U.S.C. 112(b) are withdrawn in view of Applicant’s amendments to the claims and corresponding persuasive arguments, which are detailed below. Additional rationale in the additional rejections under 35 U.S.C. 112(b) are noted to be withdrawn, however the rejection of claims 1 and 5 and subsequently 2-4 and 6-8 are maintained as detailed below with regard to the “hot weather” indefinite language. Regarding the previously raised issues under 35 U.S.C. 112, Applicant presents claim amendments, a declaration filed under 3;7 C.F.R. 1.132, and arguments. The declaration is addressed below. The declaration of Inventor Hsin-Yu Chen has been entered as filed 8/6/2026. The declarant states that in the hypothetical situation where there is no leaf surface, then there is nothing to do for a foliar spray step; in reply, this argument has been considered and is persuasive in view of the claim language clarifying that what is claimed applies to leaf surfaces when present, as amended. Applicant’s declaration also limits a reading of “hot weather condition” to paragraphs [0006] and [0007], however this argument is not persuasive in view of the indefinite claim language and the context of the specification as filed which does not define the term but rather discusses a context-specific example based on a single artisan’s potential understanding where said understanding may vary from one artisan and/or climate condition context including temperature, to another. While applicant may act as his own lexicographer, the written description must clearly define the claim term, and, in the instant case, the term is maintained indefinite because the specification does not clearly set forth a definition of the term “hot weather”. Naming an example does not constitute a definition. Regarding the double patenting rejections, Applicant argues that the terminal disclaimer includes an attachment referencing additional copending applications. However, the terminal disclaimer itself clearly states only Application No. 18/389,780. Accordingly, double patenting rejections are maintained. The terminal disclaimer approved as noted 8/16/2026 in the file wrapper names only one reference application and not the cited multiplicity of reference applications and their corresponding nonstatutory double patenting rejections. Maintained Rejections Claim Rejections - 35 USC § 112(b) The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 1-8 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claims 1 and 5 recite “under hot weather condition” in line 2 of each claim. What constitutes a hot weather condition? What temperature and/or duration and/or humidity parameter would meet the claim. As written, what constitutes hot weather is subjective and variable from one artisan’s opinion to another, and an example generally described in the specification does not constitute a definition with definite endpoints or parameters, as further discussed above in “response to arguments”. Appropriate clarification is required. Claims 1 and 5 recite problematic language as outlined above; claims 2-4 and 6-8 are rejected here since they depend from and therefore require all limitations of a rejected base claim. Withdrawn Rejections and Response to Arguments – Double Patenting Applicant’s terminal disclaimer filed 8/6/2026 has been approved as noted 8/16/26 in the file wrapper. The approved terminal disclaimer disclaims terms over claims in patent application no. 18/389,780. Applicant’s remarks at page 4 state that “Applicant hereby provided the Terminal Disclaimers (PTO/AIA /25) for the co-pending applications”, however no terminal disclaimers over any application other than 18/389,780 appear presented or approved in the record. Accordingly, the following double patenting rejections are maintained at this time, and Applicant’s assertion that the claims are in condition for allowance is premature. Maintained Rejections Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 1-8 provisionally are rejected on the ground of nonstatutory double patenting as being unpatentable over claims (“B” in Table below) as listed in the table below in copending Application Numbers (“A” in Table below) as listed in the table below(reference application). Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims pertain to a method of using a keratin hydrolysis peptide (KHP) solution by preparing a solution from mixing feathers and water in a sealed container, hydrolyzing said mixture according to specific time, pressure, and duration parameters, and using a mass spectrometer to confirm peptide content, and administering the solution to soil and/or to leaf surfaces of specified plants (“C” in Table below). The instant claims differ from the copending claims in that (1) both claim sets have slightly different but still qualitatively similar numerical amounts with regard to mass of feathers, water content percentage, and hydrolysis temperature, pressure, and duration terms and (2) the instantly claimed method applies the solution to soil around tomato plants by infusion to the soil and/or an intended spray to plant leaf surfaces, whereas the copending claims are drawn to methods of applying the solution to the soil and/or leaves of the plants, specified particularly in the table below. It would have been prima facie obvious to one of ordinary skill in the art at the time the invention was filed to adjust the hydrolysis conditions as part of routine optimization procedure as is customary in the art, with a reasonable expectation of success. One would have been motivated to do so to achieve the desired degree of hydrolysis reaction efficacy in a method of preparing a peptide solution from feathers in aqueous solution based on the copending claims’ suggestions of hydrolysis reactions for preparing keratin hydrolysis peptide solutions for enhancing crop yields and quality. Further, it would have been prima facie obvious to one of ordinary skill in the art at the time the invention was filed to substitute one for the other, the tomato crop instantly claimed for and/or in place of the crops of the copending claims as detailed in the Table above, with a reasonable expectation of success. One would have been motivated to apply the prepared solution to soil and/or leaves of alternate food or cash crops to achieve similar end results of enhanced production yield and quality of said food or cash crops. This is a provisional nonstatutory double patenting rejection because the patentably indistinct claims have not in fact been patented. New Rejections, Same Rationale Applied where Copending Claims Previously Rejected are Now Issued Claims 1-8 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-5 of Patent No. 12527269 (also listed above as provisional rejection over copending application no. 18408245), for the reasons applied above. Although the claims at issue are not identical, they are not patentably distinct from each other because both sets of claims pertain to a method of using a keratin hydrolysis peptide (KHP) solution by preparing a solution from mixing feathers and water in a sealed container, hydrolyzing said mixture according to specific time, pressure, and duration parameters, and using a mass spectrometer to confirm peptide content, and administering the solution to soil and/or to leaf surfaces of specified plants (“C” in Table above, corresponding to content listed by provisional rejection of previously copending claims). Conclusion No claim is allowed at this time. Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to AUDREA B CONIGLIO whose telephone number is (571)270-1336. The examiner can normally be reached Monday - Thursday 7:00 a.m. - 5:30 p.m.. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Hartley can be reached at 5712720616. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /AUDREA B CONIGLIO/ Primary Examiner, Art Unit 1617
Read full office action

Prosecution Timeline

Jan 31, 2024
Application Filed
Jan 08, 2026
Non-Final Rejection mailed — §112, §DP
Mar 24, 2026
Response Filed
May 13, 2026
Final Rejection mailed — §112, §DP
Aug 06, 2026
Response after Non-Final Action
Aug 06, 2026
Request for Continued Examination
Aug 07, 2026
Response after Non-Final Action
Sep 01, 2026
Non-Final Rejection mailed — §112, §DP (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12740927
MIXED SURFACTANT FOR PREPARING TRANSPARENT MICROEMULSION AND FINE NANOEMULSION, AND COSMETIC COMPOSITION PREPARED USING THE SAME
2y 6m to grant Granted Sep 22, 2026
Patent 12714658
OIL-IN-WATER EMULSIFIED COSMETIC
4y 2m to grant Granted Aug 25, 2026
Patent 12714655
WATER-IN-OIL-TYPE EMULSIFIED SUNSCREEN COSMETIC
3y 9m to grant Granted Aug 25, 2026
Patent 12656092
BALLISTIC DELIVERY METHOD AND SYSTEM FOR INJECTABLE FORMULATIONS
4y 8m to grant Granted Jun 16, 2026
Patent 12653923
ANTIMICROBIAL FIBRES
3y 11m to grant Granted Jun 16, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
53%
Grant Probability
74%
With Interview (+21.1%)
3y 3m (~7m remaining)
Median Time to Grant
High
PTA Risk
Based on 855 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month